Yu Pu
20Patents
4h-index
34Co-inventors
63Inventor score
Filing activity: Sep 20, 2001 → Aug 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7098222B2 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | Chemistry; Metallurgy | 15 | Expired |
| US7153889B2 | Bicyclic-substituted amines as histamine-3 receptor ligands | Chemistry; Metallurgy | 13 | Expired |
| US10052315B2 | Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Human Necessities | 8 | Active |
| US10449187B2 | Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Human Necessities | 4 | Active |
| US11129821B2 | Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Human Necessities | 3 | Active |
| US7662958B2 | Anti-infective agents | Human Necessities | 1 | Active |
| US9006438B2 | Processes for the preparation of an apoptosis-inducing agent | Chemistry; Metallurgy | 1 | Active |
| US6822101B2 | Process for preparing amine-substituted benzofurans | Chemistry; Metallurgy | 1 | Expired |
| US11701362B2 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide | Human Necessities | 0 | Active |
| US10653697B2 | Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Human Necessities | 0 | Active |
| US11883389B2 | Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Human Necessities | 0 | Active |
| US8273767B2 | Bicyclic-substituted amines as histamine-3 receptor ligands | Chemistry; Metallurgy | 0 | Active |
| US9238652B2 | Processes for the preparation of an apoptosis-inducing agent | Chemistry; Metallurgy | 0 | Active |
| US6710185B2 | Process for the preparation of cell proliferation inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US10543214B2 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Human Necessities | 0 | Active |
| US8816086B2 | Process for preparing cannabinoid receptor ligands | Human Necessities | 0 | Active |
| US10898488B2 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Human Necessities | 0 | Active |
| US9199992B2 | Processes for the preparation of an apoptosis-inducing agent | Chemistry; Metallurgy | 0 | Active |
| US7145005B2 | 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation | Chemistry; Metallurgy | 0 | Expired |
| US7947711B2 | Bicyclic-substituted amines as histamine-3 receptor ligands | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.